Analyst Larry Biegelsen of Wells Fargo maintained a Buy rating on Intuitive Surgical, boosting the price target to $599.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Larry Biegelsen has given his Buy rating due to a combination of factors, including Intuitive Surgical’s strong financial performance in the second quarter. The company reported revenues of $2.44 billion, marking a significant year-over-year increase of 21.4%, and earnings per share of $2.19, both surpassing market expectations.
Additionally, the company’s procedure growth guidance for 2025 was raised, indicating robust future prospects. The launch of the DV5 system in the U.S., along with strategic expansions in Europe and Japan, further supports the positive outlook. Moreover, the reduction in expected tariff impacts and the increase in gross margin guidance reflect improved operational efficiencies, contributing to the Buy rating.
In another report released today, Barclays also maintained a Buy rating on the stock with a $635.00 price target.